SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Parnes Josh

(Last) (First) (Middle)
C/O ADAPTHEALTH LLC
220 WEST GERMANTOWN PIKE, SUITE 250

(Street)
PLYMOUTH MEETING, PA 19462

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
AdaptHealth Corp. [ AHCO ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
President
3. Date of Earliest Transaction (Month/Day/Year)
01/28/2021
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Class A Common Stock 01/29/2021 D 19,597 D (1) 208,528 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Option (right to buy) (2) 01/28/2021 A 416,667 (2) (2) Class A Common Stock 416,667 (2) 416,667 D
Employee Stock Option (right to buy) $42.61 01/28/2021 A 66,600 (3) 01/28/2026 Class A Common Stock 66,600 $0 66,600 D
Employee Stock Option (right to buy) $48.17 01/28/2021 A 77,700 (4) 01/28/2026 Class A Common Stock 77,700 $0 77,700 D
Employee Stock Option (right to buy) $53.72 01/28/2021 A 90,090 (5) 01/28/2026 Class A Common Stock 90,090 $0 90,090 D
Explanation of Responses:
1. On January 29, 2021, the issuer repurchased 19,597 shares of restricted Class A Common Stock from the reporting person.
2. On December 19, 2019, the reporting person was granted an option to purchase 1,250,000 shares of Class A Common Stock of the issuer. The option vests in three equal annual installments based on the issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2020, 2021 and 2022. The performance criteria for 2020 were met, resulting in vesting of the option as to 416,667 shares.
3. Options vest in three equal annual installments, beginning on January 28, 2022.
4. Options vest in three equal annual installments, beginning on January 28, 2022.
5. Options vest in three equal annual installments, beginning on January 28, 2022.
Remarks:
*** The Power of Attorney given by the reporting person was previously filed with the U.S. Securities and Exchange Commission on November 13, 2019 as an exhibit to the Form 3 filed by the reporting person with respect to the Issuer and is hereby incorporated by reference.
/s/Chris Joyce, as attorney-in-fact for Josh Parnes*** 02/01/2021
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.